Caplin Point Lab
₹2,362
- Market Cap
- ₹17,524Cr.
- P/E Ratio
- 26.3
- P/B Ratio
- 5.33
- EPS (TTM)
- ₹89.81
- Div Yield
- 0.34%
- ROCE
- 24.2%
- ROE
- 20.9%
52W Low: ₹1,50052W High: ₹2,990
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 14.0% a year over three years.
- Debt is 0.07× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Caplin_Point_Lab — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 26.3P/E: 26.3 | P/B: 5.33Growth
GrowingSales CAGR — 3Y: 14% · 1Y: 15%Profitability
High MarginROCE: 24.2% | ROE: 20.9%Key Metrics
Valuation
PEG Ratio 1.38
Price / Sales 7.66x
Price / FCF 63.7x
Book Value ₹443
Margins & returns
Operating Margin 35%
Net Margin 29.6%
Return on Assets 16.8%